Evidence map›Paper›PMID 40305515›Full record

ArticlePloS one2025

Polyhydroxyalkanoate production in Priestia megaterium strains from glycerol feedstock.

Andrew J Cal, Victor J Chan, Winston K Luo, Charles C Lee

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Polyhydroxyalkanoate (PHA) production by landfill isolate Priestia sp. revealed by preparatory glucose-induced tests and genome-annotations.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Andrew J CalOlipha, Inc., Wilmington, Delaware, United States of America.
Victor J ChanUSDA-ARS-Western Regional Research Center, Bioproducts Research Unit, Albany, California, United States of America.
Winston K LuoUSDA-ARS-Western Regional Research Center, Bioproducts Research Unit, Albany, California, United States of America.
Charles C LeeUSDA-ARS-Western Regional Research Center, Bioproducts Research Unit, Albany, California, United States of America.ORCID 0000-0002-3606-1134

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our society relies heavily on plastic, but most plastic is petroleum-based and non-biodegradable resulting in major negative environmental impacts. Polyhydroxyalkanoates (PHAs) are a type of biopolymer that can be produced from microorganisms cultured on renewable feedstocks, such as glycerol. PHAs are biodegradable and have properties similar to petroleum-based plastics. Several Priestia megaterium isolates have been demonstrated in previous studies to produce PHA when cultured on glycerol, but there has been no comparison of strains available in public repositories. Such comparison would be useful to identify the most promising strains for further development. In this study, we screened a number of P. megaterium strains from readily accessible repositories for their ability to produce PHA from glycerol. The strains had a wide range of growth and PHA production characteristics on glycerol: cell dry weight (0.5-5.7 g/L), percent PHA (4-42%), PHA titer (0.1-1.9 g/L), and yield (26-303 mg/g). The time course of PHA production varied widely among the different strains. There was also a dramatic difference in molecular weights which ranged from 119 kD to 402 kD. This information will be valuable to groups in selecting a PHA strain to develop based on their specific requirements.

Indexed as

GlycerolPolyhydroxyalkanoatesGlycerolPolyhydroxyalkanoates

Identifiers

PMID40305515
PMCPMC12043173

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.